EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators

Balamurugan Ramatchandirin iD, Alexia Pearah, Ling He

Life · 13.02.2023 · 13 (2) · 515

DOI: 10.3390/life13020515 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 13.02.2023. Verfasst von Balamurugan Ramatchandirin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of nonalcoholic fatty liver disease (NAFLD) worldwide is on the rise and NAFLD is becoming the most common cause of chronic liver disease. In the USA, NAFLD affects over 30% of the population, with similar occurrence rates reported from Europe and Asia. This is due to the global increase in obesity and type 2 diabetes mellitus (T2DM) because patients with obesity and T2DM commonly have NAFLD, and patients with NAFLD are often obese and have T2DM with insulin resistance and dyslipidemia as well as hypertriglyceridemia. Excessive accumulation of triglycerides is a hallmark of NAFLD and NAFLD is now recognized as the liver disease component of metabolic syndrome. Liver glucose and lipid metabolisms are intertwined and carbon flux can be used to generate glucose or lipids; therefore, in this review we discuss the important transcription factors and coactivators that regulate glucose and lipid metabolism.

Schlagwörter

Stichwörter der Autor:innen

fatty liverobesitytype 2 diabetes

Autor:innen und Institutionen

  • Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, 600 N. Wolfe St, Baltimore, MD 21287, USA.

ORCID-Profile: Balamurugan Ramatchandirin

Förderung

  • the National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Ramatchandirin, B., Pearah, A., & He, L. (2023). Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators. Life, 13(2), 515. https://doi.org/10.3390/life13020515

Vancouver

Ramatchandirin B, Pearah A, He L. Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators. Life. 2023;13(2):515. doi:10.3390/life13020515

BibTeX
@article{Ramatchandirin2023,
  author = {Ramatchandirin, Balamurugan and Pearah, Alexia and He, Ling},
  title = {Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators},
  journal = {Life},
  year = {2023},
  volume = {13},
  number = {2},
  pages = {515},
  doi = {10.3390/life13020515}
}
Kostenlos starten →